Novartis India is currently trading at Rs 698.90, up by 3.70 points or 0.53% from its previous closing of Rs 695.20 on the BSE.
The scrip opened at Rs 703.85 and has touched a high and low of Rs 710.25 and Rs 683.00 respectively. So far 10222 shares were traded on the counter.
The BSE group 'B' stock of face value Rs 5 has touched a 52 week high of Rs 944.00 on 19-Sep-2011 and a 52 week low of Rs 616.50 on 24-Jan-2012.
Last one week high and low of the scrip stood at Rs 723.00 and Rs 683.00 respectively. The current market cap of the company is Rs 2230.86 crore.
The promoters holding in the company stood at 76.42% while Institutions and Non-Institutions held 2.53% and 21.05% respectively.
Novartis India has registered a fall of 28.19% in its net profit at Rs 26.98 crore for first quarter ended June 30, 2012 as compared to Rs 37.57 crore for the same quarter in the previous year. The net income from operation of the company has increased by 9.70% at Rs 219.54 crore for Q1FY13 as compared Rs 200.13 crore for the corresponding quarter previous year.
Novartis India is engaged in manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare.
Company Name | CMP |
---|---|
Redington | 193.80 |
Adani Enterprises | 2813.70 |
Amrapali Industries | 17.80 |
Rashi Peripheral | 368.05 |
Compuage Infocom | 2.71 |
View more.. |